Literature DB >> 34023410

Retinoic acid exerts neuroprotective effects against focal cerebral ischemia by preventing apoptotic cell death.

Ju-Bin Kang1, Dong-Ju Park1, Murad-Ali Shah1, Phil-Ok Koh2.   

Abstract

Cerebral ischemia is a neurological disorder that leads to cognitive decline and high mortality. Retinoic acid is a metabolite of vitamin A that has anti-inflammatory and anti-apoptotic effects. This study investigated whether retinoic acid prevents neuronal cell damage on focal cerebral ischemia through modulating apoptosis signaling pathway. Middle cerebral artery occlusion (MCAO) was performed to induce focal cerebral ischemia in adult male rats. Retinoic acid (5 mg/kg) or vehicle was injected intraperitoneally for 4 days prior to MCAO. Neurological behavior deficit tests were performed 24 h after MCAO. Brain edema and infarct volume were measured, and TUNEL histochemistry was carried out. We also investigated the changes in apoptosis-related proteins including bcl-2 family proteins and caspases. MCAO injury induced severe neurological behavior deficits and brain edema. It also increased infarct volume, histopathological damages, and the number of TUNEL-positive cells in cerebral cortex. However, retinoic acid pretreatment attenuated MCAO-induced neurological behavior deficits, brain edema, and infarction. It also alleviated histopathological lesion and decreased the number of TUNEL-positive cells. Bcl-2 and bax proteins are representative bcl-2 family proteins. MCAO injury induced a decrease in bcl-2 expression and an increase in bax expression, and retinoic acid pretreatment alleviated these changes. MCAO injury caused a decrease in bcl-2/bax expression ratio in cerebral cortex, while retinoic acid restored this decrease by MCAO. Moreover, our result showed increases in caspase-9, caspase-3, PARP protein levels in MCAO-operated animals. Retinoic acid pretreatment prevented these increases. We identified the changes in cleaved forms of these proteins, similar to the changes in full-length protein. Activation of caspases and PARP proteins are considered to be representative apoptosis indicators. This study showed that retinoic acid regulates bcl-2 family proteins and caspase proteins in focal cerebral ischemia. Thus, our findings demonstrate that retinoic acid exhibits a neuroprotective effect against ischemic damage by modulating apoptosis signaling pathway.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bcl-2; Caspase-3; Focal cerebral ischemia; Neuroprotection; Poly ADP-ribose polymerase

Mesh:

Substances:

Year:  2021        PMID: 34023410     DOI: 10.1016/j.neulet.2021.135979

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Retinoic Acid Prevents the Neuronal Damage Through the Regulation of Parvalbumin in an Ischemic Stroke Model.

Authors:  Ju-Bin Kang; Dong-Ju Park; Phil-Ok Koh
Journal:  Neurochem Res       Date:  2022-10-16       Impact factor: 4.414

2.  Retinoic acid regulates the ubiquitin-proteasome system in a middle cerebral artery occlusion animal model.

Authors:  Ju-Bin Kang; Murad-Ali Shah; Dong-Ju Park; Phil-Ok Koh
Journal:  Lab Anim Res       Date:  2022-05-13

Review 3.  Neuroprotective Effect of Physical Activity in Ischemic Stroke: Focus on the Neurovascular Unit.

Authors:  Hui Zhang; Qi Xie; Juan Hu
Journal:  Front Cell Neurosci       Date:  2022-03-04       Impact factor: 5.505

4.  Cerebroprotective effect of Aloe Emodin: In silico and in vivo studies.

Authors:  Praveen Kumar Pasala; Rizwaan Abbas Shaik; Mithun Rudrapal; Johra Khan; Mohammad A Alaidarous; Shubham Jagdish Khairnar; Atul R Bendale; Vaishali D Naphade; Ranjan Kumar Sahoo; James H Zothantluanga; Sanjay G Walode
Journal:  Saudi J Biol Sci       Date:  2021-10-08       Impact factor: 4.219

5.  Identification of changed proteins by retinoic acid in cerebral ischemic damage: a proteomic study.

Authors:  Ju-Bin Kang; Phil-Ok Koh
Journal:  J Vet Med Sci       Date:  2022-07-13       Impact factor: 1.105

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.